Remove Clinical Supply Chain Remove Medicine Remove Pharma Companies Remove Regulation
article thumbnail

Untangling the Complexities of Cell and Gene Therapy Clinical Trials: A Supply Chain Perspective 

Pharmaceutical Technology

The ability to modify or introduce genetic material in human cells in such a precise and patient-centered manner clearly constitutes a breakthrough in personalized medicine. This is due to major differences throughout the clinical supply chain in both requirements and management practices.

article thumbnail

Africa: Unleashing the potential of the new superpower in clinical trials

Pharmaceutical Technology

Africa has considerable advantages and opportunities for trialling investigational medicinal products that, if pharma companies can correctly harness, will turn the continent into a superpower for clinical trials. They need to have that assistance of access to clinical trials.”